ID: ALA5281314

Max Phase: Preclinical

Molecular Formula: C28H20FNO2

Molecular Weight: 421.47

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1ccc(ON=C(c2ccccc2)c2ccccc2)cc1)c1ccc(F)cc1

Standard InChI:  InChI=1S/C28H20FNO2/c29-25-16-14-22(15-17-25)27(31)20-13-21-11-18-26(19-12-21)32-30-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-20H/b20-13+

Standard InChI Key:  PRBURSNPNWRCRI-DEDYPNTBSA-N

Associated Targets(Human)

Monoamine oxidase B 8835 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 421.47Molecular Weight (Monoisotopic): 421.1478AlogP: 6.55#Rotatable Bonds: 7
Polar Surface Area: 38.66Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.72CX LogP: 7.54CX LogD: 7.54
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.15Np Likeness Score: -0.43

References

1. Guglielmi P, Mathew B, Secci D, Carradori S..  (2020)  Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors.,  205  [PMID:32920430] [10.1016/j.ejmech.2020.112650]

Source